130 related articles for article (PubMed ID: 9352654)
1. Bis-tropolonato derivatives of cobalt(III) complexes of bidentate aliphatic nitrogen mustards as potential hypoxia-selective cytotoxins.
Ware DC; Palmer HR; Brothers PJ; Rickard CE; Wilson WR; Denny WA
J Inorg Biochem; 1997 Nov; 68(3):215-24. PubMed ID: 9352654
[TBL] [Abstract][Full Text] [Related]
2. Bis(dialkyl)dithiocarbamato cobalt(III) complexes of bidentate nitrogen mustards: synthesis, reduction chemistry and biological evaluation as hypoxia-selective cytotoxins.
Ware DC; Palmer HR; Pruijn FB; Anderson RF; Brothers PJ; Denny WA; Wilson WR
Anticancer Drug Des; 1998 Mar; 13(2):81-103. PubMed ID: 9524553
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-selective antitumor agents. 7. Metal complexes of aliphatic mustards as a new class of hypoxia-selective cytotoxins. Synthesis and evaluation of cobalt(III) complexes of bidentate mustards.
Ware DC; Palmer BD; Wilson WR; Denny WA
J Med Chem; 1993 Jun; 36(13):1839-46. PubMed ID: 8515422
[TBL] [Abstract][Full Text] [Related]
4. Anionic carbonato and oxalato cobalt(III) nitrogen mustard complexes.
Craig PR; Brothers PJ; Clark GR; Wilson WR; Denny WA; Ware DC
Dalton Trans; 2004 Feb; (4):611-8. PubMed ID: 15252524
[TBL] [Abstract][Full Text] [Related]
5. A novel design strategy for stable metal complexes of nitrogen mustards as bioreductive prodrugs.
Parker LL; Lacy SM; Farrugia LJ; Evans C; Robins DJ; O'Hare CC; Hartley JA; Jaffar M; Stratford IJ
J Med Chem; 2004 Nov; 47(23):5683-9. PubMed ID: 15509167
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-selective antitumor agents. 12. Nitrobenzyl quaternary salts as bioreductive prodrugs of the alkylating agent mechlorethamine.
Tercel M; Wilson WR; Anderson RF; Denny WA
J Med Chem; 1996 Mar; 39(5):1084-94. PubMed ID: 8676343
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of stable bidentate transition metal complexes of 1-(chloromethyl)-5-hydroxy-3-(5,6,7-trimethoxyindol-2-ylcarbonyl)-2,3-dihydro-1H-pyrrolo[3,2-f]quinoline (seco-6-azaCBI-TMI) as hypoxia selective cytotoxins.
Milbank JB; Stevenson RJ; Ware DC; Chang JY; Tercel M; Ahn GO; Wilson WR; Denny WA
J Med Chem; 2009 Nov; 52(21):6822-34. PubMed ID: 19821576
[TBL] [Abstract][Full Text] [Related]
8. The design of cobalt(III) complexes of phenazine-1-carboxamides as prointercalators and potential hypoxia-selective cytotoxins.
Perrin LC; Wilson WR; Denny WA; McFadyen WD
Anticancer Drug Des; 1999 Jun; 14(3):231-41. PubMed ID: 10500498
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-selective antitumor agents. 14. Synthesis and hypoxic cell cytotoxicity of regioisomers of the hypoxia-selective cytotoxin 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide.
Palmer BD; Wilson WR; Anderson RF; Boyd M; Denny WA
J Med Chem; 1996 Jun; 39(13):2518-28. PubMed ID: 8691449
[TBL] [Abstract][Full Text] [Related]
10. Isomerization mechanisms of stereolabile tris- and bis-bidentate octahedral cobalt(II) complexes: X-ray structure and variable temperature and pressure NMR kinetic investigations.
Riblet F; Novitchi G; Scopelliti R; Helm L; Gulea A; Merbach AE
Inorg Chem; 2010 May; 49(9):4194-211. PubMed ID: 20353154
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-selective antitumor agents. 5. Synthesis of water-soluble nitroaniline mustards with selective cytotoxicity for hypoxic mammalian cells.
Palmer BD; Wilson WR; Cliffe S; Denny WA
J Med Chem; 1992 Aug; 35(17):3214-22. PubMed ID: 1507207
[TBL] [Abstract][Full Text] [Related]
12. [Synthesis and antitumor activity of benzoic nitrogen mustard derivatives].
Luo W; Zhao YM; Wang YX; Xie SQ; Zhao J; Wang CJ
Yao Xue Xue Bao; 2007 Dec; 42(12):1327-9. PubMed ID: 18338650
[TBL] [Abstract][Full Text] [Related]
13. Nitroimidazole-based "extruded mustards' designed as reductively activated hypoxia-selective cytotoxins.
Hay MP; Denny WA; Wilson WR
Anticancer Drug Des; 1996 Jul; 11(5):383-402. PubMed ID: 8765531
[TBL] [Abstract][Full Text] [Related]
14. New anionic cobalt complexes using highly hindered bis-amides with varying donor abilities as ligands.
Jiménez CA; Belmar JB; Alderete J; Delgado FS; López-Rodríguez M; Peña O; Julve M; Ruiz-Perez C
Dalton Trans; 2007 Jun; (21):2135-44. PubMed ID: 17514334
[TBL] [Abstract][Full Text] [Related]
15. Optimization of alkylating agent prodrugs derived from phenol and aniline mustards: a new clinical candidate prodrug (ZD2767) for antibody-directed enzyme prodrug therapy (ADEPT).
Springer CJ; Dowell R; Burke PJ; Hadley E; Davis DH; Blakey DC; Melton RG; Niculescu-Duvaz I
J Med Chem; 1995 Dec; 38(26):5051-65. PubMed ID: 8544182
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-selective antitumor agents. 9. Structure-activity relationships for hypoxia-selective cytotoxicity among analogues of 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide.
Palmer BD; Wilson WR; Atwell GJ; Schultz D; Xu XZ; Denny WA
J Med Chem; 1994 Jul; 37(14):2175-84. PubMed ID: 8035424
[TBL] [Abstract][Full Text] [Related]
17. Cobalt(III) complexes of bidentate azotyrosine analogs.
White WI; Legg JI
Bioinorg Chem; 1976; 6(2):163-77. PubMed ID: 1053538
[TBL] [Abstract][Full Text] [Related]
18. Selective hypoxia-cytotoxins based on vanadyl complexes with 3-aminoquinoxaline-2-carbonitrile-N1,N4-dioxide derivatives.
Vieites M; Noblía P; Torre MH; Cerecetto H; Laura Lavaggi M; Costa-Filho AJ; Azqueta A; de Cerain AL; Monge A; Parajón-Costa B; González M; Gambino D
J Inorg Biochem; 2006 Aug; 100(8):1358-67. PubMed ID: 16698084
[TBL] [Abstract][Full Text] [Related]
19. Structural modifications on the phenazine N,N'-dioxide-scaffold looking for new selective hypoxic cytotoxins.
Lavaggi ML; Nieves M; Cabrera M; Olea-Azar C; López de Ceráin A; Monge A; Cerecetto H; González M
Eur J Med Chem; 2010 Nov; 45(11):5362-9. PubMed ID: 20846761
[TBL] [Abstract][Full Text] [Related]
20. Bioreducible mustards: a paradigm for hypoxia-selective prodrugs of diffusible cytotoxins (HPDCs).
Denny WA; Wilson WR
Cancer Metastasis Rev; 1993 Jun; 12(2):135-51. PubMed ID: 8375017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
